BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $3.05 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.